
LSI Asia ’26 Emerging Medtech Summit
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to LSI Asia ’26 Emerging Medtech Summit — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
LSI Asia '26 Emerging Medtech Summit
Event type: Medical technology, medtech innovation, healthcare devices, digital health, regulatory, clinical commercialization, investor and partner networking
Best use case: Buyer discovery, exhibitor targeting, partnership outreach, medtech vendor prospecting, investor and commercialization intelligence
LSI Asia '26 Emerging Medtech Summit is a highly focused medtech industry event designed for innovators, device manufacturers, investors, commercialization teams, regulatory leaders, clinical stakeholders, and strategic partners across the healthcare technology ecosystem. This is not a broad consumer healthcare show. It is a specialized B2B summit where the audience typically includes senior decision-makers, product leaders, founders, business development teams, R&D leaders, investors, and companies actively looking for partnerships, distribution, clinical validation, and market expansion opportunities.
For attendee-list research and buyer targeting, this event is valuable because it attracts companies that are already active in medtech innovation and are more likely to have budget, urgency, and business intent. The strongest contacts are usually in product development, strategic partnerships, commercial leadership, regulatory affairs, clinical affairs, venture investment, and corporate development.
1) Who attends: buyers / attendees
The main attendees are medtech founders, executives, investors, product innovators, and healthcare technology professionals. In a summit like this, the buying audience is usually not a single procurement department. Instead, it is a layered ecosystem of people who influence purchases, partnerships, supplier selection, technology adoption, fundraising, and strategic growth.
Primary attendee groups include:
- Medtech founders and CEOs seeking partnerships, capital, and commercialization support
- Vice presidents and directors of product development, innovation, and R&D
- Business development, strategic partnerships, and corporate development leaders
- Regulatory affairs and quality assurance leaders
- Clinical affairs, medical affairs, and evidence generation teams
- Investor groups, venture capital firms, and private equity professionals
- Hospital innovation leaders and healthcare system procurement influencers
- Manufacturers, component suppliers, contract manufacturers, and OEM partners
- Digital health and software companies serving medtech workflows
- Service providers in design, testing, compliance, packaging, and market access
The best buyers are often the companies that can either purchase a product or influence adoption: device manufacturers, medtech startups, hospital innovation teams, and investors looking for emerging technologies.
2) Where the show is happening + attendee geographic origin
Show location: The event is positioned as an Asia-focused summit, so the location should be treated as an Asia-based venue with regional and international participation. If you share the exact city and venue, the buyer analysis can be made much sharper, especially for local coverage and travel-based targeting.
Attendee geographic origin: This event typically attracts a strong mix of attendees from across Asia, including Singapore, Malaysia, India, China, Japan, South Korea, Taiwan, Hong Kong, Thailand, Vietnam, Indonesia, and Australia, along with international participants from the United States and Europe. Because the summit is focused on emerging medtech, the audience is usually cross-border and partnership-driven.
If the event is hosted in a major medtech hub such as Singapore or another leading Asia business center, the attendee base will likely include a strong regional concentration plus a meaningful number of international executives who travel specifically for deal-making and market access conversations.
3) Audience reach: Local / National / Global
Reach type: Regional to global
Although the summit has an Asia identity, its audience reach is broader than a local trade show. Medtech is a global industry, and events of this type usually draw companies that want international visibility, partnerships, and expansion. That means the audience is best described as regional with global commercial relevance.
In practice, the summit’s reach is:
- Local: Strong presence from the host city and surrounding business ecosystem
- National: Important for companies headquartered in the host country
- Regional: Very strong across Asia-Pacific medtech markets
- Global: High-value participation from multinational device companies, investors, and service providers
4) Sample buyer company names + websites
Below is a sample buyer-target list with companies that are highly relevant to medtech innovation, devices, diagnostics, digital health, manufacturing, clinical workflows, and healthcare technology partnerships. These are buyer-style accounts, not just generic attendees.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Medtronic | medtronic.com | Director, Strategic Partnerships; VP Product Innovation; Regional Commercial Leader | Global medtech leader with ongoing need for innovation scouting, partnerships, and commercialization intelligence. |
| 2 | Abbott | abbott.com | Director, Business Development; Product Strategy Director; Clinical Affairs Leader | Strong fit for diagnostics, devices, and healthcare technology expansion. |
| 3 | Boston Scientific | bostonscientific.com | VP Innovation; Director, Corporate Development; Regulatory Affairs Director | Highly relevant to device innovation, new product development, and strategic partnerships. |
| 4 | Siemens Healthineers | siemens-healthineers.com | Director, Digital Health; Partnership Manager; Product Marketing Director | Active in healthcare systems, imaging, diagnostics, and digital health integration. |
| 5 | GE HealthCare | gehealthcare.com | Innovation Lead; Strategic Alliances Manager; Commercial Strategy Director | Strong medtech and healthcare technology buyer with global market scope. |
| 6 | Philips | philips.com | Business Development Director; Healthcare Solutions Manager; Market Access Lead | Relevant for connected care, imaging, patient monitoring, and healthcare solutions. |
| 7 | Fresenius Medical Care | freseniusmedicalcare.com | Product Manager; Clinical Strategy Lead; Regional Operations Director | Strong buyer for medical devices, therapy systems, and clinical technology. |
| 8 | BD (Becton, Dickinson and Company) | bd.com | Director, Product Development; Regulatory Affairs Manager; Market Development Manager | Large healthcare technology company with continuing need for product and market expansion. |
| 9 | ResMed | resmed.com | VP Product Strategy; Partnerships Director; Digital Health Lead | Strong fit for connected care, remote monitoring, and medtech innovation. |
| 10 | Dexcom | dexcom.com | Commercial Partnerships Manager; Product Strategy Lead; Regional Market Lead | Great fit for diabetes technology, digital health, and patient-centric device innovation. |
| 11 | Intuitive Surgical | intuitive.com | Strategic Alliances Director; Product Marketing Director; Clinical Program Manager | High-value buyer for robotics, surgical innovation, and clinical technology partnerships. |
| 12 | Stryker | stryker.com | Business Development Director; Innovation Program Manager; Regional Sales Leader | Strong medtech portfolio across devices, surgical systems, and hospital technologies. |
| 13 | Johnson & Johnson MedTech | jnj.com | Director, Corporate Development; Innovation Lead; Regulatory Strategy Manager | Large-scale medtech buyer with global innovation and partnership activity. |
| 14 | Terumo | terumo.com | Product Manager; Business Development Manager; Regional Marketing Director | Strong fit for cardiovascular, injection, blood management, and device commercialization. |
| 15 | Olympus | olympus-global.com | Director, Medical Systems; Clinical Affairs Manager; Partnership Development Lead | Relevant for endoscopy, imaging, surgical systems, and medtech innovation. |
| 16 | MicroPort | microport.com | Regional Business Director; Product Strategy Manager; Market Expansion Lead | Asia-connected medtech company with strong commercial and regional growth interest. |
| 17 | Hologic | hologic.com | Director, Global Marketing; Medical Affairs Lead; Business Development Director | Strong buyer for diagnostics, women’s health, and device commercialization. |
| 18 | Mindray | mindray.com | Regional Sales Director; Product Innovation Lead; Partnerships Manager | Very relevant for Asia medtech distribution, device growth, and healthcare technology. |
| 19 | Nipro | nipro-group.com | Commercial Strategy Manager; Product Development Director; Market Access Lead | Strong fit for medical devices, consumables, and healthcare supply chain engagement. |
| 20 | Konica Minolta Healthcare | konicaminolta.com | Healthcare Solutions Director; Digital Imaging Lead; Business Development Manager | Relevant for imaging, diagnostics, and healthcare technology partnerships. |
5) Job profiles, industries & event type
This summit is strongest for senior and mid-senior buyers in medtech, health technology, clinical commercialization, and healthcare innovation. The right job titles are not only sales-oriented; they are often strategy, product, compliance, and partnership roles.
Best job profiles to target:
- Founder / Co-Founder / CEO
- Chief Commercial Officer
- Chief Strategy Officer
- VP Product Development
- VP Innovation
- Director, Strategic Partnerships
- Director, Corporate Development
- Director, Business Development
- Director, Regulatory Affairs
- Director, Quality Assurance
- Director, Clinical Affairs
- Medical Affairs Manager
- Product Manager / Senior Product Manager
- Market Access Manager
- Commercialization Manager
- Innovation Program Manager
- Regional Sales Director
- Healthcare Solutions Director
- R&D Manager
- Venture Partner / Principal / Investment Director
Best industries to use for targeting:
- Medical Devices
- Pharmaceuticals
- Biotechnology
- Hospital & Health Care
- Health, Wellness & Fitness
- Research
- Information Technology & Services
- Computer Software
- Medical Practice
- Healthcare Consulting / Management Consulting
- Electrical / Electronic Manufacturing
- Mechanical or Industrial Engineering
- Nanotechnology
- Packaging & Containers
- Market Research
- Venture Capital & Private Equity
- Investment Management
- Professional Training & Coaching
For medtech events, the most important thing is to combine industry filters with title filters. A director in regulatory affairs or product innovation is often far more valuable than a general marketing contact, because they are closer to purchase, supplier selection, and strategic decisions.
6) Estimated attendance / expected footfall
Estimated attendance: Likely in the mid-hundreds to low-thousands range depending on the event format, speaker program, and partner participation. Since this is a focused emerging medtech summit rather than a large consumer exhibition, the value lies more in attendee quality than raw quantity.
For attendee-list sales, it is safer to position this event as a high-intent, high-quality B2B summit with a concentrated decision-maker audience. Typical footfall expectations for a summit like this would include:
- Founders and startups
- Corporate innovation teams
- Investors and venture groups
- Regulatory and clinical experts
- Device manufacturers and commercial teams
- Partner ecosystem providers
If the summit includes an expo, startup showcase, or investor networking format, buyer density increases significantly because exhibitors and attendees both become potential targets for outreach.
7) Key focus areas & buyer engagement
The most likely content pillars for this summit include medtech innovation, market access, regulatory strategy, digital health, product design, clinical evidence, fundraising, and international expansion. These topics attract decision-makers who are actively evaluating tools, partners, service providers, and new technologies.
Likely key focus areas:
- Emerging medtech innovation and startup commercialization
- Medical device product development and design
- Clinical validation and evidence generation
- Regulatory strategy and compliance
- Digital health and connected devices
- AI-enabled healthcare technology
- Market access and international expansion
- Manufacturing, quality, and supply chain support
- Investment, fundraising, and growth strategy
- Hospital partnerships and adoption pathways
Buyer engagement angle:
The strongest outreach message should focus on the commercial value of the audience, not just event attendance. For example:
“This summit connects you with medtech founders, device executives, innovation teams, investors, and healthcare technology decision-makers actively working on commercialization, partnerships, and growth.”
That positioning is stronger than a generic attendee list pitch because it speaks to business outcomes: partnership development, lead generation, market expansion, and product adoption.
8) Client product fit note
To recommend the best buyers accurately, I need your client website before finalizing the targeting strategy. The best accounts and titles change based on what your client sells.
Examples:
- If your client sells medtech software, target product leaders, digital health teams, and innovation directors.
- If your client sells clinical services or testing, target regulatory, QA, clinical affairs, and product development leaders.
- If your client sells manufacturing or component solutions, target OEMs, operations, supply chain, and engineering teams.
- If your client sells marketing, lead generation, or data services, target business development, partnerships, and commercial leadership.
- If your client sells investor or advisory services, target founders, corporate development, and venture groups.
Please share your client’s website, and I can review it and tell you the best buyers, best job titles, and best industry filters for this event.
9) Industry suggestions based on the industry list
Based on the event theme, the most relevant industry filters from your list are:
- Medical Devices
- Biotechnology
- Pharmaceuticals
- Hospital & Health Care
- Health, Wellness & Fitness
- Research
- Information Technology & Services
- Computer Software
- Management Consulting
- Market Research
- Venture Capital & Private Equity
- Investment Management
- Electrical/Electronic Manufacturing
- Mechanical or Industrial Engineering
- Nanotechnology
- Professional Training & Coaching
If you want a sharper list, the best approach is to segment by buyer intent:
- Commercial buyers: business development, partnerships, market access
- Technical buyers: product development, engineering, R&D
- Risk/compliance buyers: regulatory, QA, clinical affairs
- Capital buyers: founders, investors, corporate development
Final recommendation
LSI Asia '26 Emerging Medtech Summit is a strong B2B event for lead generation and buyer-list selling because it attracts a high-value medtech audience with real commercial intent. The best prospects are not general visitors; they are innovators, company leaders, partnership teams, investors, and decision-makers involved in product development and healthcare technology growth.
Quality rating for B2B attendee-list sales: 9/10
This is an excellent event for targeted outreach if your client serves medical devices, digital health, clinical services, manufacturing, compliance, or healthcare innovation. Share your client website, and I will narrow this down to the best-fit buyers, top titles, and most relevant companies for your exact product.
Data sheet
| Event Name | LSI Asia ’26 Emerging Medtech Summit |
| Event Date | 30 June 2026 – 2 July 2026 |
| Event Status | Upcoming |
| Venue | Official venue / session details listed on the event website; Singapore |
| City | Singapore |
| State / Region | Singapore |
| Country | Singapore |
| Organizer | Life Science Intelligence (LSI) |
| Official Event Website | LSI Asia ’26 Emerging Medtech Summit official site |
| Event Type | Specialized B2B medtech summit focused on innovation, commercialization, investment, and strategic partnerships |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Business Services; IT & Technology; Wellness, Health & Fitness |
| Audience Reach | Global medtech and healthcare innovation audience with strong Asia-Pacific participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to Medium; event is clearly positioned, but current-year public attendance totals were not confirmed in accessible official materials. |
| Main Purpose of Event | To connect medtech innovators, device companies, investors, strategic partners, and commercialization leaders for networking, business development, regulatory discussion, and partnership formation. |
LSI Asia ’26 Emerging Medtech Summit is a highly focused B2B medtech meeting designed for companies working on healthcare devices, digital health, clinical commercialization, and strategic growth. The event sits at the intersection of innovation and market access, making it relevant for organizations seeking partnerships, distribution opportunities, clinical validation, funding, and regulatory or commercial guidance.
The summit matters because it brings together the decision-makers who influence product development, investment, procurement, commercialization, and regional expansion in medtech. For lead generation and attendee profiling, it is especially valuable for targeting founders, executives, product leaders, business development teams, investors, clinical stakeholders, and regulatory specialists across the Asia-Pacific and global medtech ecosystem.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Medtech founders and CEOs | Emerging device companies, startups, scale-ups | Final decision-makers for partnerships, vendors, outsourcing, and commercialization support | High-value targets for software, CRO/CDMO, manufacturing, regulatory, and GTM services |
| Product and R&D leaders | Medical device firms, digital health companies, diagnostics innovators | Influence product roadmap, technical partnerships, and supplier selection | Relevant for engineering, materials, components, testing, and development tools |
| Commercialization and business development teams | Medtech firms, platform companies, health-tech ventures | Own partnerships, channel strategy, and market-entry execution | Strong prospects for distribution, launch services, and strategic alliances |
| Regulatory and quality leaders | Medical device manufacturers, diagnostics firms, connected-health vendors | Influence compliance, documentation, approvals, and market access readiness | Relevant for regulatory consulting, QMS, validation, and compliance software |
| Clinical affairs and medical affairs teams | Device companies, diagnostics providers, health-tech innovators | Influence evidence generation, clinical studies, adoption, and KOL engagement | Relevant for CROs, real-world evidence, and clinical data solutions |
| Investors and venture teams | VCs, medtech funds, corporate venture arms, angel investors | Capital allocation and partnership screening influence | Useful for portfolio services, diligence support, and growth-stage solutions |
| Strategic partners and corporate development | Large medtechs, pharma, health systems, platform partners | Responsible for collaborations, licensing, and M&A screening | Relevant for deal sourcing, partnerships, and enterprise integration services |
| Healthcare providers and innovation leaders | Hospitals, health systems, clinical networks, innovation centers | Influence evaluation, pilot adoption, and procurement pathways | Relevant for device pilots, digital health trials, and deployment partners |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Singapore | Local medtech, healthcare, venture, and innovation stakeholders | High | Singapore is a regional healthcare innovation and investment hub |
| Host region: Southeast Asia | Companies from Malaysia, Thailand, Indonesia, Vietnam, Philippines, and nearby markets | High | Strong regional cross-border participation is likely for medtech commercialization and partnerships |
| Nearby business hubs | Shenzhen, Hong Kong, Shanghai, Seoul, Tokyo, Bengaluru, Sydney, and regional innovation centers | Medium to High | Relevant for supply chain, investment, and commercialization outreach |
| National reach | Singapore-based SMEs, startups, hospitals, accelerators, and capital providers | High | Dense concentration of HQ, regional offices, and innovation teams in Singapore |
| International reach | Global medtech investors, strategics, and growth-stage companies | High | The summit format and industry focus support international attendance and deal-making |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The summit is positioned for international medtech stakeholders, investors, and commercialization partners, with Singapore functioning as a global business hub. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Medtronic | Strategic medtech buyer / partner | Large device platform company with ongoing interest in innovation, partnerships, and commercialization | medtronic.com | Corporate Development, BD, Innovation, R&D, Regulatory | Strong Market Fit, Attendance Not Confirmed |
| Johnson & Johnson MedTech | Strategic medtech buyer / corporate partner | Relevant for partnerships, innovation scouting, and device ecosystem engagement | jnj.com | BD, New Ventures, Innovation, Product, Regulatory Affairs | Strong Market Fit, Attendance Not Confirmed |
| Stryker | Device buyer / commercialization partner | Likely to evaluate enabling technologies, innovations, and regional expansion opportunities | stryker.com | Strategy, Product, Business Development, Clinical Affairs | Strong Market Fit, Attendance Not Confirmed |
| Abbott | Medical device / diagnostics buyer | Cross-portfolio medtech and diagnostics company with interest in innovation and commercialization | abbott.com | Innovation, Product Management, Regulatory, Corporate Development | Strong Market Fit, Attendance Not Confirmed |
| Boston Scientific | Device buyer / strategic partner | Strong fit for technologies related to interventional, clinical, and commercial expansion | bostonscientific.com | BD, R&D, Clinical, Regulatory, Strategy | Strong Market Fit, Attendance Not Confirmed |
| Philips | Healthcare technology buyer | Relevant for digital health, imaging, connected care, and ecosystem partnerships | philips.com | Strategy, Innovation, Partnerships, Clinical Informatics | Strong Market Fit, Attendance Not Confirmed |
| Siemens Healthineers | Healthcare technology buyer | Potential for diagnostics, imaging, AI, workflow, and commercialization partnerships | siemens-healthineers.com | Innovation, Product, BD, Regional GM, Regulatory | Strong Market Fit, Attendance Not Confirmed |
| ResMed | Digital health / device buyer | Relevant for connected care, home health devices, and software-enabled medtech | resmed.com | Product, Partnerships, Data, Clinical, Strategy | Strong Market Fit, Attendance Not Confirmed |
| Fresenius Medical Care | Healthcare operator / device buyer | Large clinical services and device user with ongoing procurement and innovation interests | freseniusmedicalcare.com | Procurement, Clinical Operations, Innovation, Supply Chain | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Clinical buyer / innovation partner | Leading health system relevant for pilots, validation, and clinical adoption | mayoclinic.org | Innovation, Procurement, Clinical Affairs, Digital Health | Strong Market Fit, Attendance Not Confirmed |
| National University Health System (NUHS) | Healthcare operator / buyer | Singapore-based health system relevant for pilots, evaluation, and procurement discussions | nuhs.edu.sg | Procurement, Clinical Engineering, Innovation, Operations | Strong Market Fit, Attendance Not Confirmed |
| SingHealth | Healthcare operator / buyer | Major Singapore healthcare network with strong innovation and procurement relevance | singhealth.com.sg | Innovation, Procurement, Clinical Ops, Digital Health | Strong Market Fit, Attendance Not Confirmed |
| Temasek | Investor / strategic capital | Relevant for medtech portfolio companies, growth capital, and ecosystem partnerships | temasek.com.sg | Investment, Portfolio, Venture, Healthcare Strategy | Strong Market Fit, Attendance Not Confirmed |
| Vertex Ventures | Investor / venture capital | Active in early- and growth-stage innovation ecosystems; relevant for commercial and capital conversations | vertexventures.sg | Partner, Principal, Investment, Portfolio Operations | Strong Market Fit, Attendance Not Confirmed |
| SingHealth Duke-NUS Academic Medical Centre | Clinical innovation partner | Relevant for clinical validation, translational research, and adoption pathways | singhealthdukenus.com.sg | Clinical Research, Innovation, Partnerships, Procurement | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | CEO / Founder / President | Executive Office | C-level | Owns strategic partnerships, fundraising, and commercialization decisions |
| 2 | Chief Commercial Officer / VP Commercial | Commercial | C-level / VP | Responsible for market-entry, channel strategy, and revenue partnerships |
| 3 | VP Business Development / Partnerships | Business Development | VP / Director | Key for alliance building, distribution, licensing, and co-development |
| 4 | Director of Product / Product Manager | Product | Director / Manager | Influences vendor selection, development priorities, and roadmap decisions |
| 5 | Head of Regulatory Affairs | Regulatory / Quality | Director / Head | Critical for approval pathways, compliance, and market access |
| 6 | Clinical Affairs Director / Medical Affairs | Clinical Affairs | Director | Supports evidence generation, trials, adoption, and physician engagement |
| 7 | Investor / Principal / Partner | Investment | Mid to senior | Screens companies for capital deployment and strategic alignment |
| 8 | Procurement / Sourcing Leader | Procurement / Supply Chain | Manager to Director | Purchases services, components, platforms, and outsourced capabilities |
| 9 | Head of Innovation / Corporate Development | Strategy / Innovation | Director / VP | Explores acquisitions, pilots, open innovation, and ecosystem partnerships |
| 10 | Clinical Operations / Hospital Innovation Lead | Operations / Innovation | Manager to Director | Evaluates pilots, implementation, workflow fit, and procurement pathways |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Medical Devices | Core sector of the summit | Product, BD, regulatory, and sourcing contacts |
| 2 | Biotechnology | Adjacent innovation and platform partnerships | Founders, innovation, and commercialization teams |
| 3 | Pharmaceuticals | Relevant for device-drug combination and strategic partnerships | Corporate development and alliance teams |
| 4 | Hospital & Health Care | Clinical buyers and innovation stakeholders attend such events | Hospital innovation, procurement, clinical ops |
| 5 | Medical Practice | Clinical adoption and physician champions | Clinical leads and KOLs |
| 6 | Health, Wellness & Fitness | Relevant for digital health and patient-facing solutions | Growth-stage digital health buyers |
| 7 | Hospitality | Useful if the client sells event, travel, or concierge services to delegates | Ancillary services targeting |
| 8 | Information Technology & Services | Digital health, analytics, and software-enabled medtech ecosystem | Software, integration, and data solutions |
| 9 | Information Services | Market intelligence, clinical data, and commercialization insights | Data, research, and intelligence services |
| 10 | Venture Capital & Private Equity | Investor participation is core to medtech summit networking | Capital, diligence, portfolio services |
| 11 | Research | Clinical research and product validation relevance | Evidence generation and R&D vendors |
| 12 | Management Consulting | Advisory services for commercialization and strategy | Strategic advisory and transformation projects |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed not available | Official public materials reviewed | Attendance figure not publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed | Not confirmed | Official public materials reviewed | Summit appears partnership- and networking-led rather than a broad trade fair. |
| Buyer count | Not publicly confirmed | Not confirmed | Agenda/speakers-based inference | Likely a strong executive and investor buyer mix. |
| Speaker count | Listed on official speakers page | Confirmed page exists | Official speakers page | Exact count should be verified directly on the website as the agenda updates. |
| Historical attendance | Not publicly confirmed in accessible official materials | Not confirmed | Prior-year public data not reliably surfaced | Use attendee list extraction or badge data if available through registration partners. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Medical device innovation | Faster product development and differentiation | R&D and partnership meetings | Engineering, prototyping, manufacturing, components |
| Commercialization | Market access and revenue generation | Business development outreach | Launch, channel, and commercialization services |
| Regulatory affairs | Approvals and compliance readiness | Consultative sales conversations | Regulatory consulting, QMS, documentation software |
| Clinical validation | Evidence for adoption and reimbursement | Clinical affairs introductions | CRO, RWE, study design, data services |
| Investment and fundraising | Capital, diligence, and portfolio support | Investor meetings and pipeline capture | Investor relations, diligence, analytics |
| Strategic partnerships | Distribution, licensing, and co-development | Partnering and alliance outreach | Channel, OEM, white-label, joint development |
| Digital health and data | Connected workflows and measurable outcomes | Product and IT stakeholder targeting | Software platforms, analytics, integration tools |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Strong concentration of medtech decision-makers, strategics, and investors. |
| Decision-maker availability | High | Summit format favors senior attendees and networking with executive influence. |
| Data collection potential | Medium | Useful, but current public attendee lists and counts are limited. |
| Apollo targeting potential | Very High | Clear titles, industries, and company types map well to Apollo filters. |
| Geographic targeting potential | High | Singapore, APAC, and global medtech geographies are identifiable. |
| Best outreach approach | Multi-touch account-based outreach | Use event relevance, commercialization pain points, and partnership value propositions. |
| Overall lead quality | Very High | Excellent for medtech, healthcare, investor, and strategic partnership lead generation. |
| Best use case | Buyer discovery and partnership prospecting | Best suited for lead list building, account prioritization, and executive outreach. |
| Limitations / risks | Limited public attendance disclosure | Need direct registration or exhibitor data for confirmed attendee extraction. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Medical Devices; Biotechnology; Pharmaceuticals; Hospital & Health Care; Health, Wellness & Fitness; Information Technology & Services; Venture Capital & Private Equity; Research; Management Consulting; Information Services | Capture medtech buyers, investors, clinical buyers, and commercialization stakeholders |
| Departments | Executive; Business Development; Product; R&D; Regulatory; Clinical; Procurement; Operations; Strategy; Corporate Development | Reach decision-makers and influencers |
| Seniority | C-level; VP; Director; Head; Manager; Principal | Prioritize high-intent and budget-holding contacts |
| Job titles | CEO, Founder, President, Chief Commercial Officer, VP Business Development, Head of Partnerships, Director of Product, Head of Regulatory Affairs, Clinical Affairs Director, Procurement Director, Innovation Lead, Corporate Development | Target titles most likely to engage at a medtech summit |
| Geography | Singapore; Southeast Asia; APAC; United States; Western Europe; Japan; South Korea; Australia | Balance local host-market presence with international medtech participation |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000; 5,000+ | Covers startups, growth-stage companies, and enterprise strategics |
| Keywords | medtech OR "medical device" OR "digital health" OR regulatory OR commercialization OR partnerships OR clinical affairs OR "corporate development" OR investor OR "healthcare innovation" | Improve match quality for summit-relevant contacts |
| Company type | Public company; private company; venture-backed; hospital system; research institution; investment firm | Target both buyers and strategic ecosystem participants |
| Revenue range | Relevant for enterprise strategics and growth-stage companies where available | Helps segment by budget and maturity |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| LSI Asia ’26 Emerging Medtech Summit official website | Official organizer / event site | Event positioning, summit theme, Asia focus, and overall B2B medtech context | High |
| LSI Asia ’26 speakers page | Official event directory / agenda page | Confirmed existence of speakers-related content and executive-level programming | High |
| Provided event details from user prompt | User-supplied event data | Dates, city, region, country, and event title used for report structure | Medium |
| Official event website content review | Primary source review | Category classification, audience profile, and buyer relevance | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to LSI Asia ’26 Emerging Medtech Summit — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.